Aldevron expands manufacturing capabilities in Madison

Aldevron expands manufacturing capabilities in Madison

Part of Aldevron’s expansion is a fermentation suite that will allow the company to expand its projects’ scope and scale.

Part of Aldevron’s expansion is a fermentation suite that will allow the company to expand its projects’ scope and scale.

February 10, Aldevron hosted a virtual celebration of its lab facility expansion in Madison.

Aldevron produces the raw materials that allow clients to make groundbreaking therapies, and its protein business unit has operated within University Research Park since 2009. The facility’s growth from 8,000 to nearly 30,000 square feet includes a new 3,500-square-foot fermentation suite and will allow the company to expand its projects’ scope and scale.

Aldevron founders John Ballantyne and Michael Chambers partnered with Tom Foti to establish the company’s protein business unit in Madison in 2009 to expand Aldevron’s offerings.

“Madison is rightly known around the world as a biotech hotspot, and the fact that there was a team out there ready to hit the ground running made it sort of a no-brainer,” said Ballantyne, who serves as Aldevron’s Chief Science Officer.

Speakers at the celebration pointed out that Aldevron’s partnerships with UW–Madison in research and education benefit both the company and the university.

“I watched Aldevron partner with researchers at the University of Wisconsin–Madison, with other companies at the Park, and with partners all over the globe, and it’s these partnerships that are at the very center of Aldevron’s business model,” said Aaron Olver, the Managing Director of University Research Park, a UW–Madison-affiliated nonprofit that creates neighborhoods where innovation can flourish. “So with the newly expanded capacity at the Park, I know Aldevron’s going to be able to find new partnerships and new opportunities, to push the boundaries of science even further.”

See full article and video